3rd International Conference Ophthalmology and vision Care

Dr. Craig E. Geist, MD, MS, FACS, FAAO, ASOPRS, is a board-certified ophthalmologist and highly regarded oculoplastic and orbital surgeon. His clinical expertise encompasses the diagnosis and treatment of eyelid and orbital disorders, including eyelid and orbital tumors, ptosis (drooping eyelids and eyebrows), thyroid eye disease, tear duct obstruction, and facial rejuvenation procedures. He is also experienced in cosmetic treatments such as Botox and dermal filler injections for the eyes and face. His medical degree from Virginia Commonwealth University before completing his ophthalmology residency at The George Washington University. He subsequently pursued advanced fellowship training in Oculoplastics and Orbital Surgery at Massachusetts Eye and Ear Infirmary, affiliated with Harvard Medical School.

Oculoplastics, Orbit, Lacrimal, Neuro-Ophthalmology

Dr. Darius M. Moshfeghi, MD, is a distinguished ophthalmologist and academic leader serving as an Assistant Professor at Stanford University School of Medicine. He has completed advanced fellowship training in both vitreoretinal surgery and retinal diseases, as well as ocular oncology and orbital disorders, establishing expertise across multiple subspecialties of ophthalmology. In addition to his work in pediatric retinal diseases, Dr. Moshfeghi serves as Co-Director of Ocular Oncology, where he contributes to the diagnosis, management, and research of ocular tumors and related conditions. His commitment to clinical excellence, research innovation, and healthcare technology continues to make a substantial impact on the field of ophthalmology.

Pediatric vitreoretinal disorders, advanced retinal image quantification, therapeutic approaches for age-related macular degeneration, and ocular tumor research. 

Dr. Constance L. Fry earned her Doctor of Medicine (M.D.) degree in 1988 from Tulane University School of Medicine in New Orleans. Throughout her distinguished career, she has demonstrated a strong commitment to medical education, mentorship, and ophthalmic plastic surgery. Since 1994, Dr. Fry has served as an invited instructor at a nationally recognized ophthalmology review program, where she has educated residents and recent graduates on key concepts in ophthalmic plastic and reconstructive surgery to support board examination preparation. In recognition of her expertise and leadership, she was appointed Course Director for the Ophthalmic Plastic and Reconstructive Surgery section of the review course in 2007. Through her educational contributions and clinical excellence, Dr. Fry has played an influential role in advancing ophthalmic training and professional development.

Research interests include ophthalmology, reconstructive surgery, oculoplastic procedures, and ophthalmic oncology.

Dr. Brian Francis, MD, is an Associate Professor of Ophthalmology at the Doheny Eye Institute within the Keck School of Medicine of USC and holds the prestigious Ralph and Angelyn Riffenburgh Professorship in Glaucoma. He is widely recognized for his expertise in glaucoma management, research, and innovation in ophthalmic care, completed his undergraduate studies at Stanford University and earned his medical degree from Tulane University School of Medicine. He subsequently completed his ophthalmology residency at Tulane University and advanced fellowship training in glaucoma at the University of California, San Francisco. In addition, he obtained a master’s degree in Clinical and Biomedical Investigations from the University of Southern California.

Brian A. Francis's research interests focus on neural network-based visual field analysis, virtual reality applications for visual field assessment, the development of implantable micro- and nanotechnology devices for glaucoma diagnosis and treatment, and innovative glaucoma surgical approaches, including Trabectome procedures, drainage tube implants, and endoscopic ciliary body ablation.

Dr. David Belyea, MD, MBA, FACS, is a board-certified ophthalmologist and a distinguished academic leader in the field of eye care. He serves as Vice Chair of the Department of Ophthalmology, Director of Glaucoma Services, and Professor of Ophthalmology at The George Washington University School of Medicine & Health Sciences. With extensive experience in glaucoma treatment, surgical innovation, and academic leadership, Dr. Belyea continues to play an important role in shaping the future of ophthalmic practice and education.

Glaucoma and Cataract Surgery.

Dr. David A. Goldman, MD, is a leading ophthalmologist and the founder of Goldman Eye. With extensive experience in corneal, cataract, and refractive surgery, he is recognized for his commitment to advancing vision care and improving patient outcomes. He completed his undergraduate studies at Cornell University, where he graduated with honors, before earning his medical degree from Tufts University School of Medicine, receiving distinction for his research achievements. Following his medical education, he undertook an internship at Mount Sinai–Cabrini Medical Center in New York City.

David A. Goldman's research interests include advancements in cataract and refractive surgery technologies, innovative approaches to dry eye disease management, and the integration of internet-based applications and digital solutions in ophthalmology. 

Dr. Matthew Wilson is a distinguished professor of ophthalmology at the Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis. He serves as Director of Ocular Oncology at both the Hamilton Eye Institute and St. Jude Children’s Research Hospital, where he also holds the Endowed Chair in Pediatric Ophthalmology. An accomplished clinician, researcher, and educator, Dr. Wilson has authored over 70 peer-reviewed publications and contributed to more than 100 abstracts presented at national and international scientific meetings. In recognition of his significant contributions to the field, he received the Senior Achievement Award from the American Academy of Ophthalmology in 2009.

Dr. Matthew W. Wilson's research focuses on advancing the understanding and treatment of ocular cancers, with particular interests in retinoblastoma, choroidal malignant melanoma, and the application of sentinel lymph node biopsy in the diagnosis and management of ophthalmic tumors. His work aims to improve early detection, treatment outcomes, and patient care in the field of ocular oncology. 

Dr. Brian S. McKay is a distinguished vision scientist whose research focuses on the cellular and molecular mechanisms underlying retinal and optic nerve diseases. He earned his bachelor’s degree in Biology from the University of Wisconsin–Milwaukee and subsequently completed his PhD at the Medical College of Wisconsin, where his research centered on cell biology and retinal disorders. Following his doctoral studies, Dr. McKay pursued postdoctoral training in protein chemistry at The Scripps Research Institute in San Diego, California. He later joined the faculty at Duke University, where he established a research program dedicated to investigating the biological processes involved in age-related macular degeneration (AMD) and other vision-threatening conditions.

Research interest of Brian S. McKay include Retinal degenerations and the Molecular origins of glaucoma.